This page will host Events plug-in for all Clarion and trade events.

Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

125.50 -0.46 (-0.36%)
Streaming Delayed Price Updated: 11:26 AM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Why iRhythm (IRTC) Stock Is Up Today
What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.4% in the afternoon session after the company announced posit... 
Via StockStory
Topics Artificial Intelligence
News headline image
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
From iRhythm
Via GlobeNewswire
News headline image
2 Cash-Producing Stocks for Long-Term Investors and 1 Facing Challenges
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
2 Healthcare Stocks Worth Your Attention and 1 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl... 
Via StockStory
News headline image
iRhythm (IRTC): Buy, Sell, or Hold Post Q4 Earnings?
iRhythm has gotten torched over the last six months - since October 2025, its stock price has dropped 31.2% to $125.18 per share. This might have investors c... 
Via StockStory
Topics Supply Chain
News headline image
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
From iRhythm
Via GlobeNewswire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
From iRhythm
Via GlobeNewswire
News headline image
Q4 Patient Monitoring Earnings Review: First Prize Goes to iRhythm (NASDAQ:IRTC)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at iRhythm (NASDAQ:IRTC) and its... 
Via StockStory
Topics Artificial Intelligence
News headline image
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗
RTW Investments loads up on iRhythm Holdings with 1.18M Shares Worth $210 million. iRhythm delivers wearable cardiac monitoring and analytics solutions to healthcare providers and at-risk patients. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
iRhythm Holdings Appoints Jason Patten to its Board of Directors
From iRhythm
Via GlobeNewswire
News headline image
Evolent Health and iRhythm Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. 
Via StockStory
Topics Economy Government Stocks
News headline image
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
iRhythm (NASDAQ:IRTC) Delivers Strong Q4 CY2025 Numbers
Medical technology company iRhythm Technologies (NASDAQ:IRTC) announced better-than-expected revenue in Q4 CY2025, with sales up 27.1% year on year to $208.9 million. The company’s full-year revenue... 
Via StockStory
News headline image
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
Earnings To Watch: iRhythm (IRTC) Reports Q4 Results Tomorrow
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting earnings this Thursday after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
3 Growth Stocks with Explosive Upside
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for... 
Via MarketMinute
Topics Supply Chain
News headline image
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
From iRhythm
Via GlobeNewswire
News headline image
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
News headline image
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
3 Russell 2000 Stocks Worth Investigating
The Russell 2000 (^RUT) may be overshadowed by larger indexes, but it’s full of companies with the potential to deliver high returns. A select few have the right mix of innovation, market opportunity,... 
Via StockStory
News headline image
Patient Monitoring Stocks Q3 Earnings: iRhythm (NASDAQ:IRTC) Best of the Bunch
Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
2 Reasons to Like IRTC (and 1 Not So Much)
Over the past six months, iRhythm has been a great trade, beating the S&P 500 by 27.6%. Its stock price has climbed to $187.29, representing a healthy 39.1% increase. This was partly due to its solid... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
Why iRhythm (IRTC) Stock Is Up Today
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.4% in the afternoon session after Morgan Stanley raised its price target on the stock from $195 to $205. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.